Skip to Content
주식/증권 📈 긍정적

Eli Lilly stock rises after late-stage trial of next-generation weight-loss drug

요약

Eli Lilly shares gained on Monday, after a late-stage trial of its next-generation weight-loss drug impressed analysts.